Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,392.00
Bid: 12,376.00
Ask: 12,380.00
Change: -74.00 (-0.59%)
Spread: 4.00 (0.032%)
Open: 12,466.00
High: 12,512.00
Low: 12,330.00
Prev. Close: 12,466.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Bloomberg outage, Chinese regulations send stocks into the red

Fri, 17th Apr 2015 12:02

After a solid start UK stocks sank into the red by Friday lunchtime, moving further away from recent records amid a blackout on Bloomberg computer terminals and new regulations in China on short-selling.Bloomberg's trading and information units are heavily relied upon by roughly 320,000 people around the world and were thought to be affecting trading volumes.Meanwhile, China on Friday allowed fund managers to lend stocks for short-selling to boost the supply of shares."The news from China and the continued Bloomberg issues added to the already perilous situation in Greece to create an unfriendly trading environment at the end of the week," said Spreadex analyst Connor Campbell.The FTSE 100, which rose to a high of 7,093.52 early on, was down 0.65% at 7,014.37 by midday. The index had set a new all-time closing high on Wednesday at 7,096.78.All eyes continue to be on Greece as its debt crisis dominates proceedings at the International Monetary Fund-World Bank spring meetings in Washington.Pierre Moscovici, European Commissioner for economic and financial affairs, said there is no Plan B for Greece regarding a deal over a rescue package. Meanwhile, IMF managing director Christine Lagarde denied speculation that the IMF was willing to grant a delay on the repayment of loans due next month.Yanis Varoufakis responded by saying that Greece will "compromise, compromise, compromise without 'being' compromised".Data meets forecastsIn economic data on Friday, the UK unemployment rate fell from 5.7% to 5.6% in the three months to February, its lowest since July 2008 and in line with expectations. Weekly annual earnings growth picked up more than expected from 1.6% to 1.8%.The final estimate of the Eurozone consumer price index (CPI) confirmed that prices fell at a year-on-year rate of 0.1% in March, in line with initial readings but easing from a 0.3% drop in February.US inflation figures out later on are expected to show that prices stagnated again in March, with the CPI remaining at zero.Rolls-Royce and Astrazeneca riseEngine maker Rolls-Royce was among the best performers after winning its largest-ever order, worth $9.2bn, to provide Trent 900 engines and TotalCare service support to Emirates.Astrazeneca edged higher after its eye cancer treatment, selumetinib, was given 'orphan drug' status by US regulators, which should smooth its path to full approval.GKN was trading in the red after Exane BNP Paribas downgraded the stock to 'neutral'.Engineering and consulting outfit Ricardo was in demand after expanding its rail services with the £42.5m acquisition of consultancy and assurance business Lloyd's Register Rail.Shares in Applied Graphene Materials jumped after the graphene products group reported positive results from independent coatings trials.Market MoverstechMARK 3,205.44 -0.48%FTSE 100 7,014.37 -0.65%FTSE 250 17,602.55 -0.72%FTSE 100 - RisersSevern Trent (SVT) 2,144.00p +1.08%BP (BP.) 476.75p +0.70%Rolls-Royce Holdings (RR.) 984.50p +0.46%Pearson (PSON) 1,375.00p +0.36%Ashtead Group (AHT) 1,118.00p +0.27%Persimmon (PSN) 1,735.00p +0.12%Whitbread (WTB) 5,230.00p +0.10%Randgold Resources Ltd. (RRS) 5,085.00p +0.10%Sky (SKY) 1,048.00p +0.10%London Stock Exchange Group (LSE) 2,533.00p +0.08%FTSE 100 - FallersHikma Pharmaceuticals (HIK) 2,068.00p -2.73%St James's Place (STJ) 938.50p -2.09%Tesco (TSCO) 236.10p -2.05%GKN (GKN) 364.00p -1.78%Hargreaves Lansdown (HL.) 1,215.00p -1.78%Barclays (BARC) 255.95p -1.69%Schroders (SDR) 3,286.00p -1.68%Aberdeen Asset Management (ADN) 482.20p -1.59%3i Group (III) 497.90p -1.50%International Consolidated Airlines Group SA (CDI) (IAG) 563.50p -1.49%FTSE 250 - RisersHunting (HTG) 630.00p +4.74%QinetiQ Group (QQ.) 204.00p +4.56%Debenhams (DEB) 87.95p +3.59%Zoopla Property Group (WI) (ZPLA) 197.90p +2.06%Laird (LRD) 352.50p +1.73%Pennon Group (PNN) 849.50p +1.68%WH Smith (SMWH) 1,407.00p +1.59%Playtech (PTEC) 786.50p +1.22%Soco International (SIA) 184.70p +1.15%Countrywide (CWD) 532.00p +1.14%FTSE 250 - FallersEvraz (EVR) 196.10p -4.53%Rotork (ROR) 2,536.00p -4.05%Indivior (INDV) 206.10p -3.38%Ocado Group (OCDO) 354.00p -3.28%Henderson Group (HGG) 286.10p -3.18%Allied Minds (ALM) 676.50p -3.01%NMC Health (NMC) 704.50p -2.96%Supergroup (SGP) 958.00p -2.94%FirstGroup (FGP) 100.40p -2.52%Kaz Minerals (KAZ) 235.70p -2.48%
More News
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more
3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

Read more
2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
Thursday 9 November 
3i Group PLCHalf Year Results
Apax Global Alpha LtdQ3 Results
AstraZeneca PLCQ3 Results
Auto Trader Group PLCHalf Year Results
B&M European Value Retail SAHalf Year Results
Domino's Pizza Group PLCTrading Statement
Endeavour Mining PLCQ3 Results
Flutter Entertainment PLCTrading Statement
IMI PLCTrading Statement
Indivior PLCQ3 Results
John Wood Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
National Grid PLCHalf Year Results
Regional REIT LtdTrading Statement
Renewi PLCHalf Year Results
S4 Capital PLCTrading Statement
Tate & Lyle PLCHalf Year Results
Taylor Wimpey PLCTrading Statement
TBC Bank Group PLCQ3 Results
TheWorks.co.uk PLCTrading Statement
Trakm8 Holdings PLCHalf Year Results
Urban Logistics REIT PLCHalf Year Results
Vistry Group PLCTrading Statement
WH Smith PLCFull Year Results
Wincanton PLCHalf Year Results
Wizz Air Holdings PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

Read more
1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

Read more
30 Oct 2023 09:40

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

Read more
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.